blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2454597

EP2454597 - THERAPEUTIC PEPTIDES, POLYPEPTIDES ANS NUCLEIC ACID SEQUENCES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.03.2015
Database last updated on 24.07.2024
Most recent event   Tooltip27.03.2015Application deemed to be withdrawnpublished on 29.04.2015  [2015/18]
Applicant(s)For all designated states
The University of Surrey
Guildford Surrey GU2 7XH / GB
[2012/21]
Inventor(s)01 / MORGAN, Richard
The University of Surrey
Guildford
Surrey GU2 7XH / GB
02 / PANDHA, Hardev S.
The University of Surrey
Guildford
Surrey GU2 7XH / GB
 [2012/21]
Representative(s)Lock, Graham James
Fry Heath & Spence LLP
Unit A, Faraday Court
Faraday Road
Crawley, West Sussex RH10 9PU / GB
[N/P]
Former [2012/21]Lock, Graham James
Fry Heath & Spence LLP The Gables Massetts Road Horley
Surrey RH6 7DQ / GB
Application number, filing date10742866.613.07.2010
WO2010GB01335
Priority number, dateGB2009001215513.07.2009         Original published format: GB 0912155
GB2009002132804.12.2009         Original published format: GB 0921328
[2012/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011007130
Date:20.01.2011
Language:EN
[2011/03]
Type: A1 Application with search report 
No.:EP2454597
Date:23.05.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 20.01.2011 takes the place of the publication of the European patent application.
[2012/21]
Search report(s)International search report - published on:EP20.01.2011
ClassificationIPC:G01N33/574, C07K14/82
[2012/21]
CPC:
A61K45/06 (EP,US); A61P35/00 (EP); A61P37/04 (EP);
C07K14/4702 (EP,US); C07K14/82 (EP,US); A61K38/00 (EP,US);
A61K39/00 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/21]
TitleGerman:THERAPEUTISCHE PEPTIDE, POLYPEPTIDE UND NUKLEINSÄURESEQUENZEN[2012/21]
English:THERAPEUTIC PEPTIDES, POLYPEPTIDES ANS NUCLEIC ACID SEQUENCES[2012/21]
French:PEPTIDES THÉRAPEUTIQUES, POLYPEPTIDES ET SÉQUENCES D ACIDES NUCLÉIQUES[2012/21]
Entry into regional phase01.02.2012National basic fee paid 
01.02.2012Designation fee(s) paid 
01.02.2012Examination fee paid 
Examination procedure31.01.2012Amendment by applicant (claims and/or description)
01.02.2012Examination requested  [2012/21]
15.07.2014Despatch of a communication from the examining division (Time limit: M04)
26.11.2014Application deemed to be withdrawn, date of legal effect  [2015/18]
23.12.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2015/18]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  15.07.2014
Fees paidRenewal fee
26.06.2012Renewal fee patent year 03
28.08.2013Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.07.201304   M06   Fee paid on   28.08.2013
31.07.201405   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]  - "SubName: Full=Engrailed 2; Flags: Fragment;", UniProt, (20001001), Database accession no. Q9N1W7, URL: EBI, XP002600734 [X] 1-11 * compound . *
 [X]  - UniProt, EBI, (19910201), Database accession no. P19662, XP002600735 [X] 1-11 * compound . *
 [X]  - UniProt, EBI, (20050215), Database accession no. Q5ISK3, XP002600736 [X] 1-11 * compound . *
 [Y]  - RAMMENSEE HANS-GEORG ET AL, "SYFPEITHI: Database for MHC ligands and peptide motifs", IMMUNOGENETICS, SPRINGER VERLAG, BERLIN, DE, (19991101), vol. 50, no. 3-4, doi:10.1007/S002510050595, ISSN 0093-7711, pages 213 - 219, XP002183663 [Y] 1-32 * the whole document *

DOI:   http://dx.doi.org/10.1007/s002510050595
 [T]  - Anonymous, "Epitope prediction", (20100914), Syfpeithi, URL: http://www.syfpeithi.de/Scripts/MHCServer.dll/EpitopePrediction.htm, (20100914), XP002600737 [T] * the whole document *
 [Y]  - MORGAN RICHARD ET AL, "EN2 is a highly predictive and specific urine based biomarker for prostate cancer.", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING, & 100TH ANNUAL MEETING OF THE AMERICAN-ASSOCIATION-FOR-CANCER-RESEARCH; DENVER, CA, USA; APRIL 18 -22, 2009, (200904), vol. 50, ISSN 0197-016X, page 377, XP009138716 [Y] 1-32 * abstract *
 [YD]  - MARTIN NICOLE L ET AL, "EN2 is a candidate oncogene in human breast cancer", ONCOGENE, (200510), vol. 24, no. 46, ISSN 0950-9232, pages 6890 - 6901, XP002600739 [YD] 1-32 * the whole document *

DOI:   http://dx.doi.org/10.1038/SJ.ONC.1208840
 [Y]  - BOSE ET AL, "Oncogenic role of Engrailed-2 in prostate cancer cell growzh and survival", TRANSLATIONAL ONCOGENOMICS, (2008), vol. 3, pages 37 - 43, XP002600740 [Y] 1-32 * abstract *
by applicant   - MARTIN, N.L.; SABA-EL-LEIL, M.K.; SADEKOVA, S.; MELOCHE, S.; SAUVAGEAU, G., "EN-2 is a candidate oncogene in human breast cancer", ONCOGENE, (2005), vol. 24, pages 6890 - 6901
    - CARILLO, H.; LIPMAN, D., SIAM J. APPLIED MATH., (1988), vol. 48, page 1073
    - DEVEREUX, J. ET AL., NUCLEIC ACIDS RESEARCH, (1984), vol. 12, no. 1, page 387
    - ATSCHUL, S. F. ET AL., J. MOLEC. BIOL., (1990), vol. 215, pages 403 - 410
    - ALTSCHUL, S. ET AL., NCBI NLM NIH BETHESDA, page 20894
    - ALTSCHUL, S. ET AL., J. MOL. BIOL., (1990), vol. 215, pages 403 - 410
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.